Ertuglu S 5/100mg Tab 14s
Ertugliflozin 5mg and sitagliptin 100mg for type 2 diabetes.
Ertuglu S 5/100mg Tab 14s combines ertugliflozin (SGLT2) 5mg and sitagliptin (DPP-4) 100mg for type 2 diabetes when dual therapy is needed. Take once daily as directed; may be taken with or without food.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise when combination therapy is appropriate.
Ingredients
Ertugliflozin 5mg and sitagliptin 100mg (as phosphate) per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of genital and urinary infections. Report severe abdominal pain.
Side Effects
Urinary tract infections, genital mycotic infections, nasopharyngitis. Rare: ketoacidosis, pancreatitis. Report unusual tiredness, abdominal pain, or pancreatitis symptoms.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Horizon |
| Status | Active |